The Effect of Treatment With the PathMaker Myoregulator Neuromodulation System Incorporating Trans-spinal Direct Current Stimulation (tsDCS) in Patients With Severe Hand Spasticity After Stroke
The Effect of Treatment With the PathMaker Myoregulator Neuromodulation System Incorporating Trans-spinal Direct Current Stimulation (tsDCS) in Patients With Severe Hand Spasticity After Stroke
The purpose of this study is to evaluate if 5 consecutive sessions of PathMaker anodal DoubleStim treatment, which combines non-invasive stimulation of the spinal cord (tsDCS- trans-spinal direct current stimulation) and of the median nerve at the peripheral wrist (pDCS-- peripheral direct current stimulation), can significantly reduce spasticity of the wrist and hand after stroke.
Inclusion Criteria:
Exclusion Criteria:
Focal brainstem or thalamic infarcts
Prior surgical treatments for spasticity of the upper limb
Ongoing use of central nervous system (CNS)-active medications
Ongoing use of psychoactive medications, such as stimulants, antidepressants, and anti-psychotic medications
Botox or phenol alcohol treatment within 12 weeks of enrollment
Pregnancy in women, as determined by self-report
History of spinal cord injury or weakness
Chronic pain
Peripheral neuropathy including insulin dependent diabetes as determined by case history
Presence of additional potential tsDCS risk factors: